Home/Filings/4/0001209191-18-009143
4//SEC Filing

Freddo James L 4

Accession 0001209191-18-009143

CIK 0001557421other

Filed

Feb 11, 7:00 PM ET

Accepted

Feb 12, 3:30 PM ET

Size

16.5 KB

Accession

0001209191-18-009143

Insider Transaction Report

Form 4
Period: 2018-02-08
Transactions
  • Disposition to Issuer

    Common Stock

    2018-02-08$27.00/sh3,000$81,0000 total
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-02-086,6660 total
    Exercise: $1.02Exp: 2023-09-09Common Stock (6,666 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-02-0824,0000 total
    Exercise: $8.95Exp: 2024-02-28Common Stock (24,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-02-085,0000 total
    Exercise: $7.59Exp: 2024-08-10Common Stock (5,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-02-0815,0000 total
    Exercise: $5.75Exp: 2026-06-12Common Stock (15,000 underlying)
  • Disposition to Issuer

    Stock Option (Right to Buy)

    2018-02-0820,0000 total
    Exercise: $8.35Exp: 2027-06-12Common Stock (20,000 underlying)
Footnotes (2)
  • [F1]In connection with the acquisition of the Issuer by Roche Holdings, Inc. ("Parent") on February 8, 2018, and pursuant to the terms of the Agreement and Plan of Merger by and among the Issuer, Parent and Abingdon Acquisition Corp. ("Merger Sub") dated December 21, 2017, Merger Sub acquired all of the issued and outstanding shares of Common Stock (the "Shares") for a purchase price of $27.00 per Share (the "Merger").
  • [F2]In connection with the Merger described in footnote (1), this option became fully vested and was automatically canceled and terminated and the holder became entitled to receive an amount in cash, without interest and less the amount of any tax withholding, equal to the product of (1) the number of shares of Common Stock of the Issuer underlying such option multiplied by (2) the excess, if any, of $27.00 over the exercise price per share of such option.

Issuer

Ignyta, Inc.

CIK 0001557421

Entity typeother

Related Parties

1
  • filerCIK 0001368924

Filing Metadata

Form type
4
Filed
Feb 11, 7:00 PM ET
Accepted
Feb 12, 3:30 PM ET
Size
16.5 KB